The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats

A. Hamza, A. Amin, S. Daoud

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Abstract

The therapeutic value of doxorubicin as an effective antineoplastic agent is limited by its cardiotoxic side-effects. The administration of doxorubicin (10 mg/kg) to male Wistar rats induced necrosis and apoptosis in heart tissues. It also caused oxidative stress damage as evidenced by the elevation of malondialdehyde and protein carbonyl levels and catalase activity, accompanied by the concurrent depletion of total antioxidant capacity and of superoxide dismutase level in cardiac tissues. The doxorubicin-induced cardiotoxicity and oxidative stress damage were also accompanied by increases of myeloperoxidase activity, total calcium content, and the expression of Bcl-2 protein in heart tissues. Most of these doxorubicin-induced biochemical and histological alterations were effectively attenuated by prior administration of purified standardized extract (1.5% withanolides; manufactured by Idea Sphere Inc., American Fork, UT, USA) of Withania somnifera (300 mg/kg). Thus, Withania may play a role in the protection against cardiotoxicity and thus might be a useful adjuvant therapy where doxorubicin is the cancer-treating drug.

Original languageEnglish
Pages (from-to)63-73
Number of pages11
JournalCell Biology and Toxicology
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2008

Keywords

  • Apoptosis
  • Cardiotoxicity
  • Doxorubicin
  • Protection
  • Withania

ASJC Scopus subject areas

  • Toxicology
  • Cell Biology
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats'. Together they form a unique fingerprint.

Cite this